That’s a wrap for the 25th Asia-Pacific Prostate Cancer Conference bringing together a truly multidisciplinary community of urologists, oncologists, nurses, allied health professionals, researchers and industry partners all united in advancing outcomes for with prostate cancer.
Across three days we explored groundbreaking developments in prostate cancer. The program spanned from robotic surgery and focal therapy to radiotherapy innovations, exercise oncology, management of post-prostatectomy incontinence, sexual health and psycho-oncology. The energy, exchange of ideas and collaboration across disciplines was extraordinary.
A true highlight was the prestigious Patrick C. Walsh Lecture, delivered by Professor David Penson, Vanderbilt University Medical Center, in the United States, “Screening and Detecting Prostate Cancer in 2025: A Brave New World or More of the Same?”
This year we introduced the A.J. Costello Best Abstract Award, recognising the most outstanding abstract that demonstrates innovation, scientific excellence and the potential to advance prostate cancer research and care and the recipient was Professor Michael Ng - Artificial intelligence impact on decision making regarding short term ADT prostate radiotherapy: ASTuTE trial interim results
Helen Crowe Poster Award celebrates excellence in nursing and allied health research. This award recognises innovative work that enhances patient care, supports families, and strengthens the vital role of nursing and allied health professionals in prostate cancer management. This year’s recipient was Dr Cassandra Chang - More Than Dispensing: The Expanding Role of Clinical Pharmacists in Prostate Cancer Care.
We are incredibly grateful to everyone that contributed to the success of this conference. A very special thanks to our organising committee who developed a wonderful program. The energy, collaboration and exchange of ideas have left us inspired to continue pushing boundaries. Together, we are building knowledge, fostering collaboration, and driving progress in prostate cancer care.